Charlie Hatton Selected Research

Charlie Hatton Research Topics

7	Neoplasms (Cancer) 01/2022 - 12/2007
2	Leukemia 01/2022 - 12/2019
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2019 - 01/2016
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2019
1	Multiple Myeloma 01/2016
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2014
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2014
1	Glioblastoma (Glioblastoma Multiforme) 01/2012
1	Mycosis Fungoides 02/2011
1	Carcinogenesis 06/2008
1	Carcinoma (Carcinomatosis) 06/2008
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2008
1	Endometrial Neoplasms (Endometrial Cancer) 06/2008
1	Glioma (Gliomas) 12/2007

4	ChromatinIBA 01/2022 - 08/2016
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2016
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	antineoplaston A10 (A 10)IBA 01/2022
1	VTP50469IBA 12/2019
1	Small Interfering RNA (siRNA)IBA 08/2016
1	Proteins (Proteins, Gene)FDA Link 03/2016
1	Histone DemethylasesIBA 01/2016
1	Enhancer of Zeste Homolog 2 ProteinIBA 11/2014
1	Histone-Lysine N-MethyltransferaseIBA 11/2014
1	Histones (Histone)IBA 01/2012
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2012
1	Amino Acids FDA Link 02/2011
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2011
1	Pharmaceutical PreparationsIBA 06/2008
1	EnzymesIBA 06/2008
1	Phosphotransferases (Kinase)IBA 06/2008
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2008
1	Tyrosine (L-Tyrosine)FDA Link 06/2008
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 06/2008
1	LigandsIBA 12/2007

2	Therapeutics 06/2008 - 12/2007
1	Immunotherapy 06/2016